ID

14858

Beschreibung

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score; ODM derived from: https://clinicaltrials.gov/show/NCT02476786

Link

https://clinicaltrials.gov/show/NCT02476786

Stichworte

Versionen (1)
  1. 02.05.16 02.05.16 -
Hochgeladen am

2. Mai 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02476786

Englisch

Eligibility Breast Cancer NCT02476786

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed histologically or cytologically confirmed operable invasive breast cancer defined as ct1 or t2, n0-1, and m0.
Beschreibung

Invasive breast carcinoma Operable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0205188
disease must be er+ (allred score ≥ 5) and her2-.
Beschreibung

Disease Estrogen receptor positive Human epidermal growth factor 2 negative carcinoma of breast | Allred score

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0279754
UMLS CUI [1,3]
C2316304
UMLS CUI [2]
C2919519
measurable disease defined as lesions that can be accurately measured in at least one dimension (longest diameter to be recorded) by ultrasound or mammogram.
Beschreibung

Measurable Disease | Lesion | Ultrasonics (sound) | Mammography

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C0221198
UMLS CUI [3]
C1456803
UMLS CUI [4]
C0024671
75 years of age or older.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status ≤ 2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
able to understand and willing to sign an irb approved written informed consent document (or that of legally authorized representative, if applicable).
Beschreibung

Comprehension Informed Consent Institutional Review Board Approval

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C2346499
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy and/or hormone therapy for cancer.
Beschreibung

Prior Chemotherapy Malignant Neoplasms | Prior Hormone Therapy Malignant Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0006826
UMLS CUI [2,1]
C1514460
UMLS CUI [2,2]
C0006826
a history of other malignancy ≤ 5 years previous which would preclude endocrine treatment of their cancer.
Beschreibung

Malignant Neoplasms | Hormone Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0279025
currently receiving any other investigational agents.
Beschreibung

Investigational New Drugs Other

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0205394
a history of allergic reactions attributed to compounds of similar chemical or biologic composition to any of the agents used in the study.
Beschreibung

Allergic Reaction Investigational New Drugs Compound (substance)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C1706082
uncontrolled intercurrent illness as determined by their treating physician which would limit compliance with study requirements.
Beschreibung

Disease Uncontrolled | Compliance behavior Limited

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C1321605
UMLS CUI [2,2]
C0439801
known hiv-positivity on combination antiretroviral therapy because of the potential for pharmacokinetic interactions with endocrine therapies. appropriate studies will be undertaken in patients receiving combination antiretroviral therapy when indicated.
Beschreibung

HIV Seropositivity | Antiretroviral therapy | Pharmacokinetic interaction Hormone Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C1963724
UMLS CUI [3,1]
C1868980
UMLS CUI [3,2]
C0279025
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02476786

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Invasive breast carcinoma Operable
Item
newly diagnosed histologically or cytologically confirmed operable invasive breast cancer defined as ct1 or t2, n0-1, and m0.
boolean
C0853879 (UMLS CUI [1,1])
C0205188 (UMLS CUI [1,2])
Disease Estrogen receptor positive Human epidermal growth factor 2 negative carcinoma of breast | Allred score
Item
disease must be er+ (allred score ≥ 5) and her2-.
boolean
C0012634 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C2316304 (UMLS CUI [1,3])
C2919519 (UMLS CUI [2])
Measurable Disease | Lesion | Ultrasonics (sound) | Mammography
Item
measurable disease defined as lesions that can be accurately measured in at least one dimension (longest diameter to be recorded) by ultrasound or mammogram.
boolean
C1513041 (UMLS CUI [1])
C0221198 (UMLS CUI [2])
C1456803 (UMLS CUI [3])
C0024671 (UMLS CUI [4])
Age
Item
75 years of age or older.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status ≤ 2
boolean
C1520224 (UMLS CUI [1])
Comprehension Informed Consent Institutional Review Board Approval
Item
able to understand and willing to sign an irb approved written informed consent document (or that of legally authorized representative, if applicable).
boolean
C0162340 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C2346499 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy Malignant Neoplasms | Prior Hormone Therapy Malignant Neoplasms
Item
prior chemotherapy and/or hormone therapy for cancer.
boolean
C1514457 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C1514460 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
Malignant Neoplasms | Hormone Therapy
Item
a history of other malignancy ≤ 5 years previous which would preclude endocrine treatment of their cancer.
boolean
C0006826 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
Investigational New Drugs Other
Item
currently receiving any other investigational agents.
boolean
C0013230 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Allergic Reaction Investigational New Drugs Compound (substance)
Item
a history of allergic reactions attributed to compounds of similar chemical or biologic composition to any of the agents used in the study.
boolean
C1527304 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1706082 (UMLS CUI [1,3])
Disease Uncontrolled | Compliance behavior Limited
Item
uncontrolled intercurrent illness as determined by their treating physician which would limit compliance with study requirements.
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
HIV Seropositivity | Antiretroviral therapy | Pharmacokinetic interaction Hormone Therapy
Item
known hiv-positivity on combination antiretroviral therapy because of the potential for pharmacokinetic interactions with endocrine therapies. appropriate studies will be undertaken in patients receiving combination antiretroviral therapy when indicated.
boolean
C0019699 (UMLS CUI [1])
C1963724 (UMLS CUI [2])
C1868980 (UMLS CUI [3,1])
C0279025 (UMLS CUI [3,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video